Cargando…

The influence of hydroxyurea on oxidative stress in sickle cell anemia

OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. METHODS: Oxidative stress was assessed by thiobarbituric acid reactiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Lidiane de Souza, da Silva, Danilo Grünig Humberto, Belini Junior, Edis, de Almeida, Eduardo Alves, Lobo, Clarisse Lopes de Castro, Cançado, Rodolfo Delfini, Ruiz, Milton Artur, Bonini-Domingos, Claudia Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545428/ https://www.ncbi.nlm.nih.gov/pubmed/23323065 http://dx.doi.org/10.5581/1516-8484.20120106

Ejemplares similares

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Comet Assay as a technique to evaluate DNA damage in sickle cell anemia patients
por: Barberino, Willian Marcel, et al.
Publicado: (2012)

The XmnI polymorphic site 5’ to the gene G(γ) in a Brazilian patient with sickle cell anaemia – fetal haemoglobin concentration, haematology and clinical features
por: Belini Júnior, Édis, et al.
Publicado: (2010)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia
por: Pereira-Martins, Diego A., et al.
Publicado: (2021)

Beta-S globin haplotypes in patients with sickle cell anemia: one approach to understand the diversity in Brazil
por: Okumura, Jéssika Viviani, et al.
Publicado: (2013)

Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein
por: Torres, Lidiane S., et al.
Publicado: (2016)

Correction: Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein
por: Torres, Lidiane S., et al.
Publicado: (2017)

Comment on “Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia”
por: de Souza Torres, Lidiane
Publicado: (2014)

Prevalence of β(S)-globin gene haplotypes, α-thalassemia (3.7 kb deletion) and redox status in patients with sickle cell anemia in the state of Paraná, Brazil
por: Shimauti, Eliana LitsukoTomimatsu, et al.
Publicado: (2015)

The relationship between of ACE I/D and the MTHFR C677T polymorphisms in the pathophysiology of type 2 diabetes mellitus in a population of Brazilian obese patients
por: Pirozzi, Flavio Fontes, et al.
Publicado: (2018)

Sickle cell disease: looking back but towards the future
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis
por: Torres, Lidiane de Souza, et al.
Publicado: (2015)

Iron deficiency anemia and its treatment - reply
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Anemia: winning elbow room in the field of hematology and hemotherapy
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Low-level laser therapy of leg ulcer in sickle cell anemia
por: Bonini-Domingos, Claudia Regina, et al.
Publicado: (2012)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
por: Friedrisch, João Ricardo, et al.
Publicado: (2015)

Blood donation, blood supply, iron deficiency and anemia - it is time to shift attention back to donor health
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2012)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia
por: Vinhaes, Caian L., et al.
Publicado: (2020)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Survival Probability in Patients with Sickle Cell Anemia Using the Competitive Risk Statistical Model
por: do Nascimento, Emilia Matos, et al.
Publicado: (2019)

Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira – 2014
por: da Silva Araújo, Aderson, et al.
Publicado: (2014)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia
por: Hankins, Jane S., et al.
Publicado: (2014)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia
por: Delgadinho, Mariana, et al.
Publicado: (2022)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2011)

Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia
por: Lobo, Clarisse Lopes de Castro, et al.
Publicado: (2015)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
por: Dhar, Arushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qhu0blg4pq6uoi1l9rij03bans